EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020

Xinling Xu, Emmi Andersson, Afsar Rahbar, Cecilia Söderberg-Nauclér, Piotr Nowak

HIV Medicine · 2024

DOI: 10.1111/hiv.13618 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HIV Medicine, 2024. Verfasst von Xinling Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, HIV Infections, Hospitals, University, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: InFLAMES Flagship, University of Turku and Åbo Akademi University, VR (Swedish Medical Research Council), Stockholm County Council SLL-KI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In countries with access to early antiretroviral treatment (ART), opportunistic infections caused by cytomegalovirus (CMV) in people living with HIV (PLWH) are becoming increasingly rare. As potential complications are severe, it is critical to remain aware of this important diagnosis. However, clinical characteristics and prognosis of CMV infection in PLWH in the era of modern ART have not been well described.

Methods

Here, we compiled the clinical presentation, management and outcome of CMV infection in PLWH treated at the infectious diseases clinic of Karolinska University Hospital during 2010–2020.

Results

We identified 51 cases of active CMV infection, based on detection of CMV‐DNA, mainly diagnosed in patients with CD4 T‐cell count

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsHIV InfectionsHospitals, UniversityAntiviral AgentsHumansMaleFemaleAdultMiddle AgedSwedenCD4 Lymphocyte CountAIDS-Related Opportunistic InfectionsTreatment OutcomeCytomegalovirusValganciclovir

Stichwörter der Autor:innen

AIDSHIVcytomegalovirusopportunistic infectionsretinitis

Substanzen

Antiviral AgentsValganciclovir

Autor:innen und Institutionen

  • Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine Solna, Microbial Pathogenesis Unit, BioClinicum, Karolinska Institute, Stockholm, Sweden.
  • Department of Laboratory medicine, Karolinska Institute, Stockholm, Sweden.
  • Department of Clinical Microbiology, Karolinska University Laboratory, Stockholm, Sweden.
  • Division of Neurology, Karolinska University Hospital, Stockholm, Sweden.
  • Institute of BioMedicine, Unit of Infection and Immunology, MediCity Research Laboratory, Flagship InFLAMES, Turku University, Turku, Finland.

Förderung

  • InFLAMES Flagship, University of Turku and Åbo Akademi University
  • VR (Swedish Medical Research Council)
  • Stockholm County Council SLL-KI
  • Vetenskapsrådet

Zitieren

APA

Xu, X., Andersson, E., Rahbar, A., Söderberg-Nauclér, C., & Nowak, P. (2024). Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020. HIV Medicine. https://doi.org/10.1111/hiv.13618

Vancouver

Xu X, Andersson E, Rahbar A, Söderberg-Nauclér C, Nowak P. Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020. HIV Medicine. 2024. doi:10.1111/hiv.13618

BibTeX
@article{Xu2024,
  author = {Xu, Xinling and Andersson, Emmi and Rahbar, Afsar and Söderberg-Nauclér, Cecilia and Nowak, Piotr},
  title = {Cytomegalovirus infection among people living with HIV in Sweden: Case profiles, treatment strategies and patient outcomes at Karolinska University Hospital 2010–2020},
  journal = {HIV Medicine},
  year = {2024},
  doi = {10.1111/hiv.13618}
}
Kostenlos starten →